Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stuart Iain Insider Profile
4 Followers
Stuart Iain , CSO at Foamix Pharma, holds 133.74K shares in VYNE Therapeutics (Ticker: VYNE), holds 103.64K shares in Foamix Pharma (Ticker: FOMX).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+28.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CSO
Roles that Stuart Iain holds in companies
Most Profitable Insider Trade
Stock:
Foamix Pharma
(FOMX)
(FOMX)
Rating:Informative Sell
Date:Aug 09, 2018 - Aug 09, 2019
Return:+51.60%
The most profitable trade made by Stuart Iain
Stuart Iain 's Trading History
Foamix Pharma
Feb 24, 2020
―
Uninformative Buy
―
$309.87K
VYNE Therapeutics
Apr 03, 2024
CSO
Uninformative Sell
483.56
$338.36K
List of latest transactions for each holding click on a transaction to see Stuart Iain 's performance on stock
You May Also Like
Stuart Iain insider profile FAQ
What is the percentage of profitable transactions made by Stuart Iain ?
The percentage of profitable transactions made by Stuart Iain is 100%.
What is the average return per transaction made by Stuart Iain ?
The average return per transaction made by Stuart Iain is 28.70%.
What stocks does Stuart Iain hold?
Stuart Iain holds: FOMX, VYNE stocks.
What was Stuart Iain ’s latest transaction?
Stuart Iain latest transaction was an Uninformative Sell of $483.56.
What was Stuart Iain 's most profitable transaction?
Stuart Iain ’s most profitable transaction was an Informative Sell of FOMX stock on August 9, 2018. The return on the trade was 51.60%.
What is Stuart Iain 's role in Foamix Pharma?
Stuart Iain 's role in Foamix Pharma is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.